CompletedPhase 1

Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy

United States2 participantsStarted 2015-09

Plain-language summary

The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients. The primary outcome variable will be reduction of shoulder pain.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any type of open thoracotomy or video-assisted thoracoscopic surgery (VATS) * Presence of post-operative ISP, VAS\>5/10 * American Society of Anesthesiologists Class 1 - 4 * No allergy to lidocaine Exclusion Criteria: * American Society of Anesthesiologists Class 5 * Allergy to lidocaine * Nasal pathology (e.g., deviated septum) * Bleeding diathesis * Any patient who the PI feels will be unable to comply with all protocol related procedures * Shoulder pain prior to thoracotomy

What they're measuring

Shoulder Pain Reduction

Timeframe: 90 Minutes

Trial details

NCT IDNCT02733393

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-09-05

View on ClinicalTrials.gov More Ipsilateral Shoulder Pain trials